Pneumonias

dc.contributorUniversidade Estadual Paulista (UNESP)
dc.creatorCoelho, Liana Sousa
dc.creatorTanni, Suzana Erico
dc.creatorGodoy, Irma de
dc.date2014-05-27T11:24:33Z
dc.date2016-10-25T18:28:03Z
dc.date2014-05-27T11:24:33Z
dc.date2016-10-25T18:28:03Z
dc.date2009-12-01
dc.date.accessioned2017-04-06T01:39:30Z
dc.date.available2017-04-06T01:39:30Z
dc.identifierRevista Brasileira de Medicina, v. 66, n. DECEMBER SPEC. IS, p. 13-20, 2009.
dc.identifier0034-7264
dc.identifierhttp://hdl.handle.net/11449/71433
dc.identifierhttp://acervodigital.unesp.br/handle/11449/71433
dc.identifier2-s2.0-77349106666
dc.identifierhttp://www.moreirajr.com.br/revistas.asp?fase=r003&id_materia=4189
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/892426
dc.descriptionPneumonia is an infectious disease with great morbidity and mortality worldwide. According to the current guidelines recommendations the authors reviewed the treatment of community-acquired pneumonia (CAP) and hospital-acquired pneumonia (HAP). In this paper will be presented data about etiology, clinics and diagnostic tools. © Copyright Moreira Jr. Editora.
dc.languagepor
dc.relationRevista Brasileira de Medicina
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectCommunity acquired pneumonia
dc.subjectHospital acquired pneumonia
dc.subjectPneumonia
dc.subjectamoxicillin
dc.subjectamoxicillin plus clavulanic acid
dc.subjectamoxicillin plus sulbactam
dc.subjectantibiotic agent
dc.subjectastro
dc.subjectazi
dc.subjectazithromycin
dc.subjectcefepime
dc.subjectceftazidime
dc.subjectceftriaxone
dc.subjectcefuroxime axetil
dc.subjectchlorhexidine
dc.subjectcilastatin plus imipenem
dc.subjectciprofloxacin
dc.subjectclarithromycin
dc.subjectclindal
dc.subjectclindamycin
dc.subjectimipenem
dc.subjectinfluenza vaccine
dc.subjectkefadim
dc.subjectlevofloxacin
dc.subjectlinezolid
dc.subjectmaxcef
dc.subjectmeropenem
dc.subjectmoxifloxacin
dc.subjectnovamox
dc.subjectpenicillin G
dc.subjectpiperacillin plus tazobactam
dc.subjectPneumococcus vaccine
dc.subjectprocaine penicillin
dc.subjectprocin
dc.subjectqionoflox
dc.subjectsigma clav
dc.subjectsulbacter
dc.subjectsulbamox
dc.subjectsultamicillin
dc.subjecttamiram
dc.subjecttazidem
dc.subjectteicoplanin
dc.subjecttriaxin
dc.subjecttrifamox
dc.subjectunclassified drug
dc.subjectvancomicina
dc.subjectvancomycin
dc.subjectzinacel
dc.subjectalcoholism
dc.subjectantibiotic resistance
dc.subjectantibiotic therapy
dc.subjectbacterium culture
dc.subjectblood culture
dc.subjectbronchiectasis
dc.subjectbronchus obstruction
dc.subjectclinical feature
dc.subjectcommunity acquired pneumonia
dc.subjectdiagnostic test
dc.subjectdyspnea
dc.subjectEscherichia coli
dc.subjectfever
dc.subjectHaemophilus influenzae
dc.subjecthospital infection
dc.subjecthospitalization
dc.subjecthuman
dc.subjectinfluenza
dc.subjectKlebsiella pneumoniae
dc.subjectlung abscess
dc.subjectlung lavage
dc.subjectminimum inhibitory concentration
dc.subjectmyalgia
dc.subjectMycoplasma pneumoniae
dc.subjectpneumococcal infection
dc.subjectpneumonia
dc.subjectpolymerase chain reaction
dc.subjectProteus
dc.subjectpulse oximetry
dc.subjectrisk factor
dc.subjectSerratia marcescens
dc.subjectStreptococcus pneumoniae
dc.subjectthorax radiography
dc.titlePneumonias
dc.typeOtro


Este ítem pertenece a la siguiente institución